Vanguard Capital Management
TMO icon

Vanguard Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Vanguard Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2B Sell
24,276,316
-4,500
-0% -$2.16M 0.26% 61
2026
Q1 		$11.9B Buy
+24,280,816
New +$13.2B 0.3% 54

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Capital Management's TMO Position: Q2 2026 in Review

Vanguard Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.02% in Q2 2026, selling an estimated $2.16M and leaving 24,276,316 shares worth $12.2B. The position accounts for 0.26% of the portfolio, ranked #61.

Vanguard Capital Management first reported a position in TMO in Q1 2026 and has held it in 2 quarters since. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Vanguard Capital Management held 24,276,316 shares of Thermo Fisher Scientific worth $12.2B as of Q2 2026.
  • Vanguard Capital Management sold 4,500 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.16M.
  • Thermo Fisher Scientific made up 0.26% of Vanguard Capital Management's portfolio in Q2 2026, its #61 holding.
  • Vanguard Capital Management first reported a position in Thermo Fisher Scientific in Q1 2026 and has held it in 2 quarters since.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.